-- The London Proteomics Discussion Group --
Proteomics seminar series for the South East
We are a free, local proteomics seminar series in the South East,
with a focus towards networking, discussion and supporting early career researchers.
The LPDG...
was founded to bring together the large community of proteomics scientists all working in and around London. We aim to provide a space for discussion, with a focus on methods and early career researchers (two fundamental building blocks of good research!), on all topics related to proteomics. The meetings comprise of research talks framed by a proteomics methods challenge, lunch, refreshments and pizza - they are free to attend thanks to sponsorship.
Meeting Dates:
These seminars would not be possible without our amazing sponsors.
If you are interested in sponsoring an LPDG seminar,
please get in touch at sponsor@londonproteomics.co.uk
for 29th February 2024 Time 12:00
Primary Sponsor | Waters Guest Speaker: Dr Harry Whitwell |
Secondary Sponsor | ATG Scientific Ltd. |
Would you like to present at an LPDG meeting? Email: speaker@londonproteomics.co.uk
Research presentations from:
Andrew joined Kinomica from Thermo Scientific where he was a proteomics and biopharma expert for 7 years, prior to which he spent 13 years as an academic working on proteomic analysis of various cancer and stem cell systems at the Universities of Manchester and Leeds.
Manuel obtained his PhD at the University College London under Prof. Richard Jenner supervision Later, in the same lab as a post-doctoral Research Fellow, he discovered that JAZF1-SUZ12 fusion protein is sufficient to dysregulate gene expression of primary human endometrial stromal cells. Now, as CRUK-funded Research Associate in the Tate group, his work is focused on merging proteomic studies of S-acylation site identification with developing mutational screens via Crispr/Cas9 editing to understand their relevance in cancer cell models.
Georgina graduated with a bachelor’s degree in chemistry form the University of Warwick in 2014. After a year out she completed a masters in analytical chemistry followed by a PhD specialising in proteomics at the University of Warwick. Georgina is now a postdoctoral research associate in the Thalassinos lab at UCL. The work focuses on using structural mass spectrometry techniques to analyse proteins implicated in the progression of Huntington’s disease. Her work mostly focuses on proteomics and crosslinking, but she has also performed native mass spectrometry.
Dr Pavel Shliaha is the head of the Proteomics and Metabolomics Facility at the MRC Laboratory of Medical Sciences (LMS). He joined the facility in December 2021. As a post-doctoral researcher at the University of Southern Denmark, Pavel secured a Lundbeck Foundation Grant study histone PTMs. After a post-doc at the proteomics core facility at Memorial Sloan Kettering Cancer Centre, he worked at Merck characterising antibody drug stability.
Professor Gunter is Chair in Cancer Epidemiology and Prevention in the Department of Epidemiology and Biostatistics at the School of Public Health, Imperial College London and co-directs the Cancer Epidemiology and Prevention Research Unit and the Institute of Cancer Research. His main research focus is the role of nutrition, diabetes, and obesity in cancer development and prognosis. Marc serves as joint coordinator of the European Prospective Investigation into Cancer (EPIC) and currently leads several large-scale projects employing molecular approaches within prospective cohorts and intervention studies.